Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

In vivo cardioprotective effect of withacoagulin (20β, 27-Dihydroxy-1-oxo-(22R)-witha-2, 5, 24-tetraenolide) in experimental myocardial infarction in albino rats.

Breadcrumb

  • Home
  • In vivo cardioprotective effect of withacoagulin (20β, 27-Dihydroxy-1-oxo-(22R)-witha-2, 5, 24-tetraenolide) in experimental myocardial infarction in albino rats.

Hoda Quaisul 1 * and Modi Ketan P 2

1 Ph.D scholar, R K University, Gujarat, India.
2 Directorate of Technical Education, Gandhinagar, Gujarat, India.
 
Research Article
World Journal of Advanced Research and Reviews, 2020, 05(01), 036-042
Article DOI: 10.30574/wjarr.2020.5.1.0109
DOI url: https://doi.org/10.30574/wjarr.2020.5.1.0109
 
Received on 19 December 2019; revised on 12 January 2020; accepted on 13 January 2020
 
The present study was designed to evaluate the in vivo effect of withacoagulin isolated from Withania coagulans fruits in preventing myocardial infarction in rats.  Effect of withacoagulin was compared with Vitamin E, a known cardioprotective antioxidant. Male albino rats (120–150 g) were divided into five experimental groups (n=8): Normal control, Toxic (isoprenaline) control, withacoagulin (25 mg/ kg) per se, Vitamin E control (100 mg/kg, p.o.) and withacoagulin treatment group (25 mg/kg; p.o.). After treatment of 28 days to the animals of withacoagulin and vitamin E group, the rats in the isoprenaline toxic control and withacoagulin/vitamin E treatment group were given isoprenaline (85 mg/kg; s.c.) on day 29 and day 30, at an interval of 24 hour to induce myocardial infarction. On day 31st, the animals were euthanized using CO2 chamber and hearts were removed for histopathological and biochemical studies. Biochemical assessment showed significant decrease (P<0.05) in glutathione level. Highly significant decrease (P<0.01) in the level of superoxide dismutase, catalase, creatinine phosphokinase and lactate dehydrogenase has been observed. A highly significant increase (P<0.01) in lipid peroxidation marker malonyldialdehyde level was observed in the hearts of isoprenaline control rat as compared to normal control rat. On histopathological examination, myocardial damage was further confirmed due to injected isoprenaline. Withacoagulin (25 mg/ kg) showed a strong cardioprotective effect in isoprenaline-induced myonecrosis in rat. Augmentation of endogenous antioxidants and maintenance of the myocardial antioxidant status may contribute to its cardioprotective effect.
 
Withacoagulin; Withania coagulans; Vitamin E; Isoprenaline; Myocardial infarction; Cardioprotection.
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2019-0109.pdf

Preview Article PDF

Hoda Quaisul and Modi Ketan P. In vivo cardioprotective effect of withacoagulin (20β, 27-Dihydroxy-1-oxo-(22R)-witha-2, 5, 24-tetraenolide) in experimental myocardial infarction in albino rats.. World Journal of Advanced Research and Reviews, 2020, 5(1), 036-042. Article DOI: https://doi.org/10.30574/wjarr.2020.5.1.0109

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution